Eris Lifesciences Limited CC-Nov25.pdf · 2025-11-12
Yeah. Okay. Good. Sachin, would you like to chip in?
Okay. To answer your first question, INR 700 crores to INR 800 crores is the annualized revenue potential from the order book. And as Amit explained earlier, it will ramp up over a period of time depending on which dossier gets approved at what time. And second question was, what is the kind of outlook for the int ernational business? So, we had outlined two aspirations a few months . - INR 700 crores revenue by FY28 and INR 1,000 crores revenue by FY30. So, we retain those aspirations. And from the current momentum, it looks like we are well on our way. Rahul Agarw al: Got it. We seem to have made significant investments on GLP -1 manufacturing and now making more with Levim, which is a different route. For GLP-1, will we look at manufacturing only for India or are we also potentially going to use the manufacturing base for international markets?